The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
